B-cell receptor (BCR) specific for meningococcal polysaccharide, diphtheria, tetanus, and pertussis epitopes (BCR)

B-cell receptors (BCRs) specific for meningococcal polysaccharide, diphtheria, tetanus, and pertussis epitopes are the primary immunological targets for combination vaccines designed to provide multi-pathogen protection. These receptors are membrane-bound immunoglobulins located on the surface of B lymphocytes, where they function to recognize and bind specific antigenic determinants (epitopes) from Neisseria meningitidis, Corynebacterium diphtheriae, Clostridium tetani, and Bordetella pertussis (Janeway et al., 2001, Immunobiology). Upon binding to their respective antigens—often delivered as toxoids or polysaccharide-protein conjugates—the BCRs initiate intracellular signaling cascades that lead to B-cell activation, proliferation, and differentiation into memory B cells and antibody-secreting plasma cells (CDC, 2021, Pink Book). This process is fundamental to the development of adaptive immunity and long-term protection against invasive meningococcal disease, respiratory diphtheria, tetanus (lockjaw), and pertussis (whooping cough). In clinical practice, the efficacy of vaccines targeting these receptors is measured by the induction of protective antibody titers, such as serum bactericidal activity for meningococcus and antitoxin levels for diphtheria and tetanus (FDA, 2023, Menactra Label). The use of carrier proteins like diphtheria or tetanus toxoids in conjugate vaccines is a key strategy to enhance the B-cell response to polysaccharides by recruiting T-cell help, thereby ensuring a robust and lasting immune memory.

Other names

Surface immunoglobulinAntigen-specific B-cell receptorsIgMeningococcal-DTP specific B-cell receptor

Vaccine antigens (polysaccharides, toxoids, or acellular proteins) bind to specific B-cell receptors, triggering receptor-mediated endocytosis, antigen processing, and presentation to T-helper cells. This interaction induces B-cell proliferation and differentiation into memory B cells and plasma cells that secrete high-affinity neutralizing antibodies (IgG) against the respective pathogens (Pollard et al., 2009, Nature Reviews Immunology).